Literature DB >> 17001861

[Retrospective evaluation of brucellosis cases inhabiting in Mus province].

Dede Sit, Ali Kemal Kadiroğlu, Hasan Kayabaşi, Salih Hoşoğlu.   

Abstract

The aim of this study was to evaluate the brucellosis patients inhabiting in Mus province, in Eastern Anatolia of Turkey, retrospectively. The mean age of the patients (n: 87) was 38.1 +/- 12.4 years, and 45% of them were female. The transmission route was the consumption of unpasteurized fresh cheese (in 85%), and unboiled milk (in 45%). The most common symptoms were recorded as chills (89%), fever (87%), and arthralgia (81%). Splenomegaly (71%) and hepatomegaly (63%) were the predominant physical examination signs. Diagnosis was made based on the clinical features and positive Rose-Bengal test result (93%), however, blood cultures could not be performed due to insufficient laboratory equipment. In 92% of the patients at least one complication has been detected indicating delayed admission to the hospital, while the most common complications were sacroileitis (79%) and spondylitis (44%). Streptomycin+doxycyclin, streptomycin+doxycyclin+ ciprofloxacin, and streptomycin+doxycyclin+ rifampicin combination therapies were used in 62%, 24% and 14% of the patients, respectively, for six weeks, resulting with complete cure.

Entities:  

Mesh:

Year:  2006        PMID: 17001861

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  2 in total

1.  Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.

Authors:  Mile Bosilkovski; Ljiljana Krteva; Marija Dimzova; Ivan Vidinic; Zaklina Sopova; Katerina Spasovska
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

2.  Epidemiological and Clinical Features of People with Malta Fever in Iran: A Systematic Review and Meta-Analysis.

Authors:  Mahmood Moosazadeh; Roja Nikaeen; Ghasem Abedi; Motahareh Kheradmand; Saeid Safiri
Journal:  Osong Public Health Res Perspect       Date:  2016-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.